A7FIG2 AF NFT

Glutamyl-tRNA reductase

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeifpu24ls7dwdcyijjctavnsgmt36obpo2c4pot4wavmbyiaa5ods4/metadata.json
IPFS of structure file: 
bafybeihmgvb5dgtgylpj3kllgokvl26xs65czf5t6m54goz6yeta6bij4u/AF-A7FIG2-F1-model_v2.pdb
First NFT owner address (eip-55): 
0xf7Ea384D3b95C3A242403Fdf8e5bA55488D27a6b
First NFT owner address (bech32): 
genesis17l4rsnfmjhp6ysjq8l0cuka92jydy7ntfnaf42
Current NFT ID #167000 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1

NFT id:
167000
Accession (UniProt):
A7FIG2
Name::
Glutamyl-tRNA reductase
Experimental Method:
Predicted structure
Sequence source:
Yersinia pseudotuberculosis serotype O:1b (strain IP 31758)

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT A7FIG2 research and analysis (ICN3D with VR)

FASTA sequences

>sp|A7FIG2|HEM1_YERP3 Glutamyl-tRNA reductase OS=Yersinia pseudotuberculosis serotype O:1b (strain IP 31758) OX=349747 GN=hemA PE=3 SV=1 MTLLALGINHKTAPVSLRERVTFSPESMDQALNSLLQQPLVQGGVVLSTCNRTELYLSVEQQENLHEQLTAWLCNYHKLSPDDVRQSLYWHHGNDAVRHLMRVASGLDSQVLGEPQILGQVKKAFAESQRGQSLSSELERLFQKSFSVAKRVRTETEIGASAVSVAFAACSLARQIFESLSELHVLLVGAGETIELVARHLREHQVKHMIIANRTRERAQSLASEVGAEVITLPEIDARLADADIIISSTASPLPIIGKGMVERALKTRRNQPMLFIDIAVPRDIEPEVGKLSNAYLYSVDDLQAIIQHNMAQRQAAAVQAESIVQQESMNFMTWLRAQGAVETIRDYRSQAEQVRSEMTAKALVAIEQGANVEQVINELAYKLTNRLIHAPTKSLQQAASDGDMERLQLLRDSLGLDQH